I agree.
I find it very interesting that we are talking about tens of billions of dollars, and yet they cite 100 percent failure ...
I find it offensive to the taxpayer that we would mitigate that.
THIS IS, IN MY EYES, AN OPEN ACT OF CONTEMPT OF CONGRESS AND THOSE RESPONSIBLE NEED TO BE HELD ACCOUNTABLE.
Clearly, science has taken a back seat to ideology with this administration--THAT NEEDS TO BE CORRECTED NOW.
I do not think that what you have put out here in your outlines are suitable for reform.
Do you think that your recommendations to the FDA are sufficient to mitigate this problem?
I think part of our problem--I'm looking here at a drug recall, or a drug-in-stock affidavit as of yesterday.
This is critical mass. It's not just with pharmaceuticals but also our medical devices.
GAO Responses to Questions for the Record
What other assets do we have there? I mean, this is critical mass that can turn money very, very quickly.